Immunocore Holdings (IMCR) EBITDA Margin (2023 - 2026)
Immunocore Holdings' (IMCR) quarterly EBITDA Margin came in at 5.33% in Q1 2026, down 74.0% year-on-year from 20.49% in Q1 2025, and up 119.78% quarter-over-quarter from 26.93% in Q4 2025.
Immunocore Holdings (IMCR) EBITDA Margin (2023 - 2026) Analysis & Trends
Immunocore Holdings has disclosed EBITDA Margin across 4 years of filings, most recently posting 5.33% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 5.33%, down 74.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.23% (down 143.0% YoY), and the FY2025 annual result was 7.46%, up 821.0% from the prior year.
- EBITDA Margin came in at 5.33% for Q1 2026 at Immunocore Holdings, up from 26.93% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 14.93% in Q3 2024 to a low of 33.39% in Q1 2024.
- The 4-year median for EBITDA Margin is 14.15% (2024), against an average of 11.42%.
- Across the five-year window, EBITDA Margin tumbled 3055 bps in 2024 and soared 3945 bps in 2025, its largest moves.
- Immunocore Holdings' EBITDA Margin stood at 0.82% in 2023, then tumbled by 3747 bps to 31.36% in 2024, then grew by 14 bps to 26.93% in 2025, then surged by 120 bps to 5.33% in 2026.
- The last three EBITDA Margin figures came in at 5.33% (Q1 2026), 26.93% (Q4 2025), and 3.44% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | - |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | - |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | - |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | 5.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.33% |
| Dec 31, 2025 | -26.93% |
| Sep 30, 2025 | -3.44% |
| Jun 30, 2025 | -3.90% |
| Mar 31, 2025 | 6.07% |
| Dec 31, 2024 | -31.36% |
| Sep 30, 2024 | 14.93% |
| Jun 30, 2024 | -14.15% |
| Mar 31, 2024 | -33.39% |
| Dec 31, 2023 | -0.82% |
| Sep 30, 2023 | -21.66% |
| Jun 30, 2023 | -17.14% |
| Mar 31, 2023 | -21.98% |